Hangzhou Molecular Biotech Co., Ltd. is a professional biotechnology enterprise specializing in the research, development, and supply of instruments, reagents, and consumables for genetic testing and molecular diagnostics. Based in Hangzhou, China, the company operates as a key subsidiary of Shanghai Molecular Biomedical Technology Co., Ltd., functioning as part of an integrated group that includes specialized manufacturing and sales entities. The company serves as both a manufacturer and trading company, offering comprehensive OEM, ODM, and contract manufacturing services to the global market.
The company's core technological portfolio features industry-leading platforms, including the Micro-Chamber Controlled Nucleic Acid Diagnostic System (MCC) and rapid real-time fluorescence quantitative PCR (POCT-qPCR) systems. Their extensive product range includes handheld PCR devices, nucleic acid extraction systems, microfluidic chips, ELISA kits, and high-end laboratory consumables such as disposable sampling swabs and Taq DNA polymerase. These solutions are widely applied in medical diagnosis, scientific research, disease prevention, animal and plant quarantine, and forensic identification.
Supported by a parent group that maintains over 5,000 square meters of R&D centers and cleanroom facilities, Hangzhou Molecular Biotech utilizes modern production and assembly systems capable of producing all categories of in-vitro diagnostic reagents. The organization is driven by scientific innovation, backed by more than ten invention patents and a dedicated team of R&D professionals. With an annual output value reaching up to US$2.5 million, the company is committed to establishing a leading position in the international molecular diagnostics field through professional innovation and pragmatic efficiency.
Hangzhou Yiguoren Biotechnology Co., Ltd., also known by the brand name YUGOMED®, is a professional manufacturer and trading company established in 2014. Based in Hangzhou, China, the company specializes in the research, development, and production of sterile medical devices and in vitro diagnostic (IVD) reagents. Operating with a workforce of 51 to 100 employees, the firm integrates development, registration, and global trade to serve hospitals, clinics, and medical facilities worldwide.
The company's extensive product portfolio focuses on clinical biological sample collection, preservation, and diagnostics. Key offerings include cervical cytology brushes for HPV DNA testing, disposable sterile flocked swabs, virus collection and preservation tubes, and transport medium systems. They also provide advanced laboratory equipment such as cytology centrifuges, automated membrane filtration slide processors, and TCT liquid-based cell detection consumables. Additionally, the company produces diagnostic kits, including SARS-CoV-2 and Influenza A&B antigen combined detection tests.
As a National High-tech Enterprise, Hangzhou Yiguoren Biotechnology maintains a strong commitment to innovation through automated production lines and specialized R&D centers. The company offers OEM and ODM services, ensuring high-quality manufacturing standards. Their commitment to quality is demonstrated by multiple international certifications, including ISO 13485:2016, EU MDR-CE, US FDA, and China NMPA registration, facilitating their expansion into diverse international markets.
12 Piece Cell Slides Centrifuge for Laboratory TCT Machinery$620
Medical Automatic Machinery Centrifuge for LBC/TCT Laboratory Use$710